ResWebsite_Logo_01 (1).png

demonstrate cost & quality impact of medicines switching on care pathways

A key goal for optimising brand uptake is to demonstrate to customers the comparative positive impact of the brand on overall disease pathways outcomes and costs. The Res Comparative Value Impact Tool (CVIT) provides an online platform for achieving this through detailed mapping of disease pathway medicines (and other items such as diagnostics) to provide a baseline profile against which brand switching impact can be demonstrated. The CVIT package includes:

  • Detailed mapping of disease pathway with cost and outcome metrics
  • Comparison function to demonstrate impact of switching to brand on overall care pathway costs and outcomes
  • Scaled against estimated patient activity through pathway

Note that care pathway element data may require sourcing through bespoke stakeholder survey if not available online as published  data sets or from other sources.


For more information please contact us